OKKLUSIONSVORRICHTUNG

Patent europeic · EP4011303 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP4011303
Numer da la dumonda
EP22154998
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
07-12-2016
Publitgà
15-06-2022
Concedì
12-06-2024
Stritgà
23-07-2025
Motiv
Taxa annuala betg pajada
Classas IPC
A61B 17/12 (2006.01)
A61B 90/00 (2016.01)
Prioritad
US 201562264171 P 07.12.2015
Derivà da
EP16808631
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 23-07-2025

    Stritgà, taxa betg pajada

    Status of protective title
    Active → Cancelled
    Cancellation date
    23.07.2025
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 23.07.2025

  2. 23-04-2025

    Midada

    Published in Swissreg on 23.04.2025

  3. 26-06-2024

    Owner

    Owner
    Cerus Endovascular Limited, John Eccles House, Oxford Science Park, Oxford, Oxfordshire OX4 4GP, United Kingdom → Stryker Ireland Technology Ltd., IDA Business & Technology Park, Carrigtwohill, Co., Cork T45 HX08, Ireland

    Published in Swissreg on 26.06.2024

  4. 12-06-2024

    Concedì

    Published in Swissreg on 12.06.2024

Partidas

Possessur

Stryker Ireland Technology Ltd.

IDA Business & Technology Park Carrigtwohill, Co., Cork T45 HX08, IE

Inventur

GRIFFIN, Stephen

San Jose, California, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.